The inhibition of adrenergic alpha-receptors and tryptamine receptors by macusine B.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004837:Epinephrine / Q000378:metabolism*; D004876:Ergot Alkaloids / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000470:Alkaloids; D004876:Ergot Alkaloids; D013565:Sympatholytics; D013566:Sympathomimetics; D012701:Serotonin; D003983:Dibenzylchlorethamine; D008238:Lysergic Acid Diethylamide; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine